Trade name: COAGUCHEK XS PT TESTSTRIPS 6 tests //. Technical name: SELF-TEST FOR COAGULATION PARAMETERS //. ANVISA registration number: 10287410553 //. Risk class: III (High Risk) //. Affected lots: 11911822; 20646321; 20335921; 23343322; 23194921; 23073621 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Roche Diagnóstica Brasil Ltda; Roche Diagnostics GmBH 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1971
  • 날짜
    2016-07-29
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    Actions to be taken by the user: Roche Diagnóstica invites the users of the product involved to contact the company to request a new box, duly accompanied by instructions for use in Portuguese. The user should contact Roche Diagnóstica, through the telephone 0800-772-0295, forwarding a copy of the invoice of the product purchased between 07/01/2015 and 08/10/2016. Within 10 business days, the user will receive the new product. The company is also available to answer any queries, by calling 0800-772-0295, or e-mail brasil.vozdocliente@roche.com -xxxxxxxxxxxxxxxxxxxxx-xxxxxxxxxxxxx- If you wish to notify technical complaints and adverse events, please use the channels below: Notivisa: Notices of adverse events (EA) and technical complaints (QT) for products subject to Sanitary Surveillance should be made through the NOTIVISA System. To access the System, you must register and select the Health Professional option, if you are a liberal professional or the Institution / Entity option, if you are a professional of an institution / entity. Technovigilance System: Patient or citizen can notify through the Technovigilance System / SISTEC access through the link #### UPDATED ON 08/22/2017, the company sent a report of completion of the field action proving the sending and communication to customers regarding the misconception of the product shipment without the instructions for use.
  • 원인
    The coaguchek xs pt test strips product, 6 units, code 04625374190, was supplied without the accompanying instructions for use in english.
  • 조치
    Field Action No. RDB_2016_001 triggered under the responsibility of Roche Diagnóstica Brasil. Correction of Instructions for Use - Requires Alert Message on large circulation media.

Manufacturer